Banner

Association between Interleukin-6 Promoter Polymorphism (-174 G/C), Serum Interleukin-6 Levels and severity of sepsis

• 2022
Back
Publication Information
Authors 1Mysa S. Mostafa*, 2Ahmed W. Mahedy, 1Amany K. Shahat
Keywords Not Available
Journal Not Available
Publisher Not Available
Volume Not Available
Issue Not Available
Pages Not Available
publication.type Local
Paper Link Not Available
Supplementary Materials Not Available
Abstract
Background: Sepsis is a complicated clinical syndrome resulting from inflammatory reactions to bacteria or their products. IL-6 is a potent inflammatory cytokine produced by many cells, such as leucocytes, monocytes, endothelial cells, and fibroblasts. IL-6 plays an important role in the immune response and inflammation reactions regulation. Objective: the present study aimed to detect if IL-6 serum level and polymorphism correlate with severity of sepsis. Methodology: The study includes 70 subjects, 50 patients (Case) were chosen with at least 2 SIRS criteria and 20 healthy who were age matched. The patients were categorized into systemic inflammatory response syndrome (SIRS), sepsis, severe sepsis, septic shock and multi-organ dysfunction syndrome (MODS) according to ACCP/SCCM. Bactec Culture on automated blood culture system (Bact/ALERT 3D) was used as a gold standard method to prove sepsis . Serum IL-6 was measured by Enzyme linked immunosorbent assay (ELISA). Genotyping of the IL-6–174 G/C promoter polymorphism was performed using restriction fragment length polymorphism (RFLP) analysis. Results: Our study reported a statistically high significant difference of the IL-6 values between the case and control groups where p